Cargando…

Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities

Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerab...

Descripción completa

Detalles Bibliográficos
Autor principal: Galat, Andrzej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745455/
https://www.ncbi.nlm.nih.gov/pubmed/28961224
http://dx.doi.org/10.3390/biom7040072
_version_ 1783288906308911104
author Galat, Andrzej
author_facet Galat, Andrzej
author_sort Galat, Andrzej
collection PubMed
description Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerable level whereas their points isoelectric (pIs) are contained from 4 to 11. These two families of peptidylprolyl cis/trans isomerases (PPIases) have several distinct functional attributes such as: (1) high affinity binding to some pharmacologically-useful hydrophobic macrocyclic drugs; (2) diversified binding epitopes to proteins that may induce transient manifolds with altered flexibility and functional fitness; and (3) electrostatic interactions between positively charged segments of PPIases and negatively charged intracellular entities that support their spatial integration. These three attributes enhance binding of PPIase/pharmacophore complexes to diverse intracellular entities, some of which perturb signalization pathways causing immunosuppression and other system-altering phenomena in humans.
format Online
Article
Text
id pubmed-5745455
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-57454552018-01-02 Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities Galat, Andrzej Biomolecules Review Analyses of sequences and structures of the cyclosporine A (CsA)-binding proteins (cyclophilins) and the immunosuppressive macrolide FK506-binding proteins (FKBPs) have revealed that they exhibit peculiar spatial distributions of charges, their overall hydrophobicity indexes vary within a considerable level whereas their points isoelectric (pIs) are contained from 4 to 11. These two families of peptidylprolyl cis/trans isomerases (PPIases) have several distinct functional attributes such as: (1) high affinity binding to some pharmacologically-useful hydrophobic macrocyclic drugs; (2) diversified binding epitopes to proteins that may induce transient manifolds with altered flexibility and functional fitness; and (3) electrostatic interactions between positively charged segments of PPIases and negatively charged intracellular entities that support their spatial integration. These three attributes enhance binding of PPIase/pharmacophore complexes to diverse intracellular entities, some of which perturb signalization pathways causing immunosuppression and other system-altering phenomena in humans. MDPI 2017-09-29 /pmc/articles/PMC5745455/ /pubmed/28961224 http://dx.doi.org/10.3390/biom7040072 Text en © 2017 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Galat, Andrzej
Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title_full Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title_fullStr Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title_full_unstemmed Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title_short Peptidylprolyl Isomerases as In Vivo Carriers for Drugs That Target Various Intracellular Entities
title_sort peptidylprolyl isomerases as in vivo carriers for drugs that target various intracellular entities
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5745455/
https://www.ncbi.nlm.nih.gov/pubmed/28961224
http://dx.doi.org/10.3390/biom7040072
work_keys_str_mv AT galatandrzej peptidylprolylisomerasesasinvivocarriersfordrugsthattargetvariousintracellularentities